• 1
    Noon L & Cantab B. Prophylactic inoculation against hay fever. Lancet 1911;56i:1572.
  • 2
    Freeman J. “Rush” inoculation, with a special reference to hay fever treatment. Lancet 1930;56i:744747.
  • 3
    Asero R. Effects of birch pollen-specific immunotherapy on apple allergy in birch pollen-hypersensitive patients. Clin Exp Allergy 1998;56:13681373.
  • 4
    Asero R. Fennel, cucumber, and melon allergy successfully treated with pollen-specific injection immunotherapy. Ann Allergy Asthma Immunol 2000;56:460462.
  • 5
    Oppenheimer JJ, Nelson HS, Bock SA, Christiansen F & Leung DYM. Treatment of peanut allergy with rush immunotherapy. J Allergy Clin Immunol 1992;56:256262.
  • 6
    Nelson HS, Lahr J, Rule R, Bock SA & Leung DYM. Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract. J Allergy Clin Immunol 1997;56:744751.
  • 7
    Briner TJ, Kuo MC & Keating KM, et al. Peripheral T-cell tolerance induced in naïve and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d 1. Proc Natl Acad Sci USA 1993;56:76087612.
  • 8
    Norman PS, Ohman Jl Jr & Long AA, et al. Treatment of cat allergy with T-cell reactive peptides. Am J Resp Crit Care Med 1996;56:16231628.
  • 9
    Hong S, Michael JB, Fehringer A & Leung DYM. Pepsin-digested peanut contains T-cell epitopes but no IgE epitopes. J Allergy Clin Immunol 1999;56:473477.
  • 10
    Stanley JS, King N & Burks AW, et al. Identification and mutational analysis of the immunodominant IgE binding epitopes of the major peanut allergen Ara h 2. Arch Biochem Biophys 1997;56:244253.DOI: 10.1006/abbi.1997.9998
  • 11
    Li X-M, Serebrisky D & Lee SY, et al. A murine model of peanut anaphylaxis: T- and B-cell responses to a major peanut allergen mimic human responses. J Allergy Clin Immunol 2000;56:150158.
  • 12
    Speigelberg HL, Orozco EM & Roman M, et al. DNA immunization: a novel approach to allergen-specific immunotherapy. Allergy 1997;56:964970.
  • 13
    Slater JE, Zhang YJ & Arthur-Smith A, et al. A DNA vaccine inhibits IgE responses to the latex allergen Hev b 5 in mice. J Allergy Clin Immunol 1997;56:S504.
  • 14
    Roy K, Mao HQ, Huang SK & Leong KW. Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat Med 1999;56:387391.DOI: 10.1038/7385
  • 15
    Chu RS, Targoni OS, Krieg AM, Lehman PV & Harding CV. CpG oligodeoxynucleotides act as adjuvant that switch on T helper 1 (Th1) immunity. J Exp Med 1997;56:16231631.
  • 16
    Hus C-H, Chua KY & Tao MH, et al. Immunoprophylaxis of allergen-induced immunoglobulin E synthesis and airway hyperresponsiveness in vivo by genetic immunization. Nat Med 1996;56:540544.
  • 17
    Bohle B, Jahn-Schmid B, Maurer D, Kraft D & Ebner C. Oligonucleotides containing CpG motifs induce IL-12, IL-18 and IFN-gamma production in cells from allergic individuals and inhibit IgE synthesis in vitro. Eur J Immunol 1999;56:23442353.DOI: 10.1002/(SICI)1521-4141(199907)29:07<2344::AID-IMMU2344>3.0.CO;2-R
  • 18
    Tighe H, Takabayashi K & Schwartz D, et al. Conjugation of immunostimulatory DNA to the short ragweed allergen Amb a 1 enhances its immunogenicity and reduces its allergenicity. J Allergy Clin Immunol 2000;56:124134.
  • 19
    Nayak A, LaForce C & Rowe M, et al. rhuMab-E25 improves quality of life in patients with seasonal allergic rhinitis (SAR). J Allergy Clin Immunol 1999;56:S49.
  • 20
    Milgrom D, Fick R, Su J, Reiman J, Bush R, Watrous M & Metzger W. Treatment of allergic asthma with monoclonal anti-IgE antibody. N Engl J Med 1999;56:19661973.